EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Digoxin Dosing Errors, Drug Interactions and Off-Label Risks: Insights from an EudraVigilance Disproportionality Analysis

Emilia Sorina Fiat, Laurentiu Stoicescu iD, Ioana Rada Popa Ilie iD, Razvan Constantin Vonica, Anca Butuca iD, Carmen Maximiliana Dobrea iD, Adina Frum iD, Claudiu Morgovan iD, Florina Batar iD, Crina Cristina Solomon iD, Felicia Gabriela Gligor iD

Journal of Clinical Medicine · 31.07.2026 · 15 (15) · 5983

DOI: 10.3390/jcm15155983 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 31.07.2026. Verfasst von Emilia Sorina Fiat und 10 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral School, Faculty of Medicine, "Lucian Blaga" University of Sibiu, 550169 Sibiu, Romania. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Lucian Blaga University of Sibiu, “Lucian Blaga” University of Sibiu.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Digoxin, a positive inotropic agent with a narrow therapeutic window, is used in heart failure but carries toxicity risks. This study aims to characterize the profile of digoxin-associated adverse drug reactions reported in the EudraVigilance database, focusing on drug–drug interactions, dosing errors, and off-label use.

Methods

Descriptive and disproportionality analyses were performed on Individual Case Safety Reports (ICSRs) until 25 January 2026. Digoxin was compared with other inotropic agents by calculating the Reporting Odds Ratio and 95% confidence intervals.

Results

Digoxin recorded 11,426 ICSRs, with a predominance in patients aged 65–85 years (46.4%) and over 85 years (25.1%). Higher reporting probabilities were identified for the terms “Drug interaction” and “Overdose” compared to other inotropes. Fatal outcomes were reported in 19 cases related to drug interactions and 41 cases related to overdose. Consistent disproportionality signals were found for gastrointestinal, renal, and nervous system disorders. Off-label use was reported in 0.8% of cases and was associated with unfavorable clinical outcomes. Risks are exacerbated by polypharmacy and renal decline in elderly patients.

Conclusions

Digoxin toxicity and cardiac complications are the primary drivers of reported morbidity. This risk profile highlights the need for the rigorous clinical monitoring, precise dose adjustments and heightened vigilance regarding drug–drug interactions.

Schlagwörter

Stichwörter der Autor:innen

EudraVigilanceadverse drug reactionsdosing errorsdrug interactionsheart failureinotrope agentsoff-label usepharmacovigilance

Autor:innen und Institutionen

  • Doctoral School, Faculty of Medicine, "Lucian Blaga" University of Sibiu, 550169 Sibiu, Romania.
  • Department of Cardiology, County Clinical Emergency Hospital, 550245 Sibiu, Romania.
  • Department of Cardiology, Vth Medical Clinic, Faculty of Medicine, "Iuliu Haţieganu" University of Medicine and Pharmacy, 400139 Cluj-Napoca, Romania.
  • Department of Endocrinology, Faculty of Medicine, "Iuliu Haţieganu" University of Medicine and Pharmacy, 3-5 Louis Pasteur Street, 400349 Cluj-Napoca, Romania.
  • Preclinical Department, Faculty of Medicine, "Lucian Blaga" University of Sibiu, 550169 Sibiu, Romania.

ORCID-Profile: Laurentiu Stoicescu, Ioana Rada Popa Ilie, Anca Butuca, Carmen Maximiliana Dobrea, Adina Frum, Claudiu Morgovan, Florina Batar, Crina Cristina Solomon, Felicia Gabriela Gligor

Förderung

  • Lucian Blaga University of Sibiu
  • “Lucian Blaga” University of Sibiu

Zitieren

APA

Fiat, E. S., Stoicescu, L., Popa Ilie, I. R., Vonica, R. C., Butuca, A., Dobrea, C. M., Frum, A., Morgovan, C., Batar, F., Solomon, C. C., & Gligor, F. G. (2026). Digoxin Dosing Errors, Drug Interactions and Off-Label Risks: Insights from an EudraVigilance Disproportionality Analysis. Journal of Clinical Medicine, 15(15), 5983. https://doi.org/10.3390/jcm15155983

Vancouver

Fiat ES, Stoicescu L, Popa Ilie IR, Vonica RC, Butuca A, Dobrea CM, et al. Digoxin Dosing Errors, Drug Interactions and Off-Label Risks: Insights from an EudraVigilance Disproportionality Analysis. Journal of Clinical Medicine. 2026;15(15):5983. doi:10.3390/jcm15155983

BibTeX
@article{Fiat2026,
  author = {Fiat, Emilia Sorina and Stoicescu, Laurentiu and Popa Ilie, Ioana Rada and Vonica, Razvan Constantin and Butuca, Anca and Dobrea, Carmen Maximiliana and Frum, Adina and Morgovan, Claudiu and Batar, Florina and Solomon, Crina Cristina and Gligor, Felicia Gabriela},
  title = {Digoxin Dosing Errors, Drug Interactions and Off-Label Risks: Insights from an EudraVigilance Disproportionality Analysis},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {15},
  pages = {5983},
  doi = {10.3390/jcm15155983}
}
Kostenlos starten →